EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSMZEG00005002311
Gene Symbol: GRM4
3 Cross references
207 Possible Orthologues:

Glutamate Receptor 1

Ensembl ID : ENSMZEG00005024663
Gene Symbol: LOC101470434
3 Cross references
247 Possible Orthologues:

Glutamate Receptor 1

Ensembl ID : ENSMZEG00005008118
Gene Symbol: LOC101467141
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSMZEG00005015135
Gene Symbol: LOC101477932
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSMZEG00005015863
Gene Symbol: LOC101486592
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSMZEG00005010846
Gene Symbol: LOC101467283
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSMZEG00005015459
Gene Symbol: LOC101475684
3 Cross references
205 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a

Ensembl ID : ENSMZEG00005012457
Gene Symbol: LOC101467440
2 Cross references
98 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSMZEG00005016517
Gene Symbol: LOC101481152
2 Cross references
212 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b

Ensembl ID : ENSMZEG00005014111
Gene Symbol: LOC101484174
2 Cross references
226 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 2

Ensembl ID : ENSMZEG00005018179
Gene Symbol: LOC101474374
2 Cross references
253 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSMZEG00005026579
Gene Symbol: GRM5B
1 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).